Summary
Researchers have demonstrated that clove (Syzygium aromaticum) has significant effects on reducing blood sugar and fat levels. In vitro, in vivo, and in silico models have observed mechanisms involving the modulation of enzymes related to glucose and lipid metabolism. Authors R. Manikandan and collaborators highlight that clove may act in reducing hyperglycemia and hyperlipidemia, conditions that affect metabolic health. The results suggest that bioactive compounds present in clove may positively influence glycemic and lipid control, offering a natural alternative for managing these conditions. However, it is important to consider that the studies were conducted in different models, and more research is needed to confirm these findings in humans.
Key points
- Clove has been shown to reduce glucose levels by up to 30% in in vitro models.
- Hypolipidemic activity was observed with a reduction of up to 25% in cholesterol levels in in vivo models.
- The bioactive compounds in clove act on the inhibition of enzymes such as alpha-glucosidase, which regulates glucose absorption.
- In silico results indicate potential for clove in modulating metabolic pathways related to diabetes.
- Limitations include the need for validation in clinical studies with humans.
✦ For you
If you are looking for natural ways to assist in controlling blood sugar and fat levels, consider including clove in your diet. Try adding clove to teas, dishes, or desserts. Observe how your body reacts, and if you notice significant changes, seek a qualified health professional.
For practitionersExpand
Consider including clove (Syzygium aromaticum) in formulas for patients with hyperglycemia or hyperlipidemia. Assess patient responses to clove use, especially in combination with other herbs that act on metabolism. Research suggests that clove may be an effective adjunct, but individualization of treatment is essential.